In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks and how they are continuously growing across the globe, with each one containing hundreds of thousands of samples that allow researchers to advance their knowledge on a range of diseases, including which individuals might be most at risk and how they will respond to certain treatments. This growing pool of knowledge contributes to the overall goal of safeguarding the future generation’s health.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/Applying-standardised-NMR-spectroscopy.pdf” width=”100%” height=”900px” style=”border:0;”]